Arcus Biosciences, Inc. (RCUS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Arcus Biosciences, Inc. (RCUS) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

RCUS Cash Flow Statement

Arcus Biosciences, Inc. (RCUS) cash flow statement — 10-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-257M	-138M	-120M	-97M	-133M	-132M	-100M	26M	-94M	-2M	-88M	-63M	-57M	-98M	-69.74M	-80.96M	-65M	654M	-62.1M	-53.76M
Operating CF Margin %	-626.83%	-811.76%	-363.64%	-373.08%	-83.13%	-471.43%	-384.62%	54.17%	-241.03%	-1.38%	-283.87%	-196.88%	-196.55%	-392%	-207.22%	-245.33%	-240.74%	3633.34%	-17.52%	-568.2%
Operating CF Growth %	-93.23%	-4.55%	-20%	-473.08%	-41.49%	-6500%	-13.64%	141.27%	-64.91%	97.96%	-26.18%	22.18%	12.31%	-114.98%	-12.3%	-50.6%	12.16%	1086.19%	-24.5%	-124.86%
Net Income	-219M	-128M	-106M	-135M	0	-112M	-94M	-92M	-93M	-4M	-81M	-71M	-75M	-80M	-67.46M	-64.92M	-67M	-67.99M	279.37M	-77.97M
Depreciation & Amortization	5M	2M	3M	2M	2M	3M	3M	2M	2M	3M	5M	1M	2M	4M	3.43M	3.61M	2M	3.43M	2.47M	1.65M
Stock-Based Compensation	34M	19M	15M	14M	15M	16M	17M	19M	20M	20M	0	18M	18M	0	0	0	15M	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-29M	0	0	0	0	0	0	0	0
Other Non-Cash Items	1M	0	-2M	1M	-2M	-2M	-3M	-4M	-4M	16M	12M	27M	-2M	16M	14.82M	15.18M	3M	21.1M	16.34M	15.88M
Working Capital Changes	-78M	-31M	-30M	21M	-148M	-37M	-23M	101M	-19M	-37M	-24M	-9M	0	-38M	-20.54M	-34.83M	-18M	697.46M	-360.29M	6.69M
Change in Receivables	0	8M	0	4M	0	5M	-4M	12M	7M	13M	0	11M	-2M	6M	-8.9M	5.32M	-6M	715.27M	-15.82M	302K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	6M	0	0	0	0	0	0	0	0
Change in Payables	0	-3M	0	13M	8M	3M	5M	-1M	0	-1M	2M	6M	-19M	10M	8.05M	-12.16M	4M	8.14M	651K	-1.85M
Cash from Investing	166M	114M	-182M	79M	137M	32M	51M	-29M	63M	-169M	28M	11M	26M	129M	46.81M	23.45M	-215M	-268.06M	18.91M	-88.61M
Capital Expenditures	0	0	-1M	0	0	-1M	-1M	-1M	0	-4M	-6M	-10M	-5M	-3M	-380K	-1.32M	-1M	-2.79M	-8.51M	-7.86M
CapEx % of Revenue	-	-	3.03%	-	-	3.57%	3.85%	2.08%	-	2.76%	19.35%	31.25%	17.24%	12%	1.13%	3.99%	3.7%	15.49%	2.4%	83.06%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	-21M	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	21M	0	0	-250K	2.75M	-6M	0	0	0
Cash from Financing	19M	3M	286M	8M	52M	142M	-2M	48M	2M	229M	3M	6M	23M	1M	11.2M	2.53M	4M	14.93M	11.67M	1.32M
Debt Issued (Net)	0	0	0	0	49M	0	0	47M	0	0	0	0	0	0	5M	0	0	5M	0	0
Equity Issued (Net)	19M	3M	286M	8M	3M	142M	3M	2M	3M	228M	3M	5M	20M	1M	6.2M	2.53M	-10M	9.93M	6.67M	1.32M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	-2M	1M	-1M	1M	0	1M	3M	0	0	0	14M	0	5M	0
Net Change in Cash	-72M	-21M	-16M	-10M	56M	42M	-51M	45M	-29M	58M	-57M	-46M	-8M	32M	-11.65M	-54.98M	-276M	400.87M	-31.52M	-141.05M
Free Cash Flow	-257M	-138M	-121M	-97M	-133M	-133M	-101M	25M	-94M	-6M	-94M	-73M	-62M	-101M	-70.12M	-82.28M	-72M	651.21M	-70.61M	-61.62M
FCF Margin %	-626.83%	-811.76%	-366.67%	-373.08%	-83.13%	-475%	-388.46%	52.08%	-241.03%	-4.14%	-303.23%	-228.13%	-213.79%	-404%	-208.35%	-249.32%	-266.67%	3617.85%	-19.92%	-651.25%
FCF Growth %	-93.23%	-3.76%	-19.8%	-488%	-41.49%	-2116.67%	-7.45%	134.25%	-51.61%	94.06%	-34.06%	11.28%	13.89%	-115.51%	0.69%	-33.53%	10.08%	1030.88%	-37.37%	-128.63%
FCF per Share	-2.04	-1.10	-1.13	-0.91	-1.25	-1.35	-1.10	0.27	-1.03	-0.07	-1.25	-0.98	-0.85	-1.38	-0.97	-1.14	-1.00	9.15	-0.94	-0.88
FCF Conversion (FCF/Net Income)	2.82x	1.08x	1.22x	0.72x	16.63x	1.18x	1.06x	-0.28x	1.01x	0.50x	1.09x	0.89x	0.76x	1.23x	1.03x	1.25x	0.97x	-9.62x	-0.22x	0.69x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0